Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?4.65

?4.65

 
WKN: 564868 / Symbol: DRRX / Name: DURECT / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€4.65
01.04.24
-
buy
03.03.24
-
17.02.24
-
16.09.23
-
14.09.23
-
buy
26.08.23
-
Your prediction

Durect Corp. Stock

Currently there is a rather negative sentiment for Durect Corp. with 2 Buy predictions and 4 Sell predictions..
On the other hand, the target price of 4 € is above the current price of 0.37 € for Durect Corp., so the potential is actually 969.52%.
Our community identified positive and negative aspects for Durect Corp. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Durect Corp. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Durect Corp. in the next few years

Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Durect Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Durect Corp. - - - - - - -
Ardelyx Inc. -0.830% -3.012% 18.340% 119.939% 24.810% 27.681% -
Evolus Inc -1.630% 4.310% 14.151% 34.444% 33.702% 59.211% -
Salarius Pharmaceuticals Inc. 0.970% -1.887% -0.952% -63.826% -25.045% -98.487% -99.993%

Comments

Prediction Buy
Perf. (%) -
Target price 4.653
Change
Ends at 01.04.25

DURECT Co. (NASDAQ: DRRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $5.00 price target on the stock.
Ratings data for DRRX provided by MarketBeat
Show more

DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for DRRX provided by MarketBeat
Show more

DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for DRRX provided by MarketBeat
Show more